文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Yuki Iida
发表
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease
Y. Eguchi, A. Nakajima, R. Loomba, 2021, Alimentary pharmacology & therapeutics.